Plant ID: NPO10628
Plant Latin Name: Boswellia papyrifera
Taxonomy Genus: Boswellia
Taxonomy Family: Burseraceae
NCBI TaxonomyDB:
1461607
Plant-of-the-World-Online:
127060-1
Unknown.
Eritrea; Chad; Sudan; Ethiopia; Uganda; Nigeria; Cameroon; Benin
PTPN1; PTPN2; | |
PTGES; | |
CA1; CA7; CA12; CA9; | |
NR1H4; | |
ALOX5; | |
PREP; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | PTGES | Prostaglandin E synthase | O14684 | CHEMBL5658 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Protein Phosphatase | PTPN2 | T-cell protein-tyrosine phosphatase | P17706 | CHEMBL3807 |
Serine protease | PREP | Prolyl endopeptidase | P48147 | CHEMBL3202 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 4.930E-11 | 1.073E-06 | CA1, CA12, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.116E-09 | 2.304E-05 | CA1, CA12, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.868E-09 | 3.533E-05 | CA1, CA12, CA7, CA9 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 9.914E-07 | 2.906E-03 | CA1, CA12, CA7, CA9, NR1H4, PTPN1 |
BP | GO:0009987; cellular process | GO:1902202; regulation of hepatocyte growth factor receptor signaling pathway | 1.447E-06 | 3.485E-03 | PTPN1, PTPN2 |
BP | GO:0050896; response to stimulus | GO:0046626; regulation of insulin receptor signaling pathway | 1.818E-06 | 3.599E-03 | NR1H4, PTPN1, PTPN2 |
CC | GO:0044464; cell part | GO:0005641; nuclear envelope lumen | 6.743E-06 | 9.789E-03 | ALOX5, PTGES |
BP | GO:0009987; cellular process | GO:1903897; regulation of PERK-mediated unfolded protein response | 1.083E-05 | 1.474E-02 | PTPN1, PTPN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 7.476E-11 | 8.971E-10 | CA12, CA1, CA7, CA9 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 4.187E-04 | 2.512E-03 | ALOX5, PTGES |
09150 Organismal Systems | 09152 Endocrine system | hsa04614 | Renin-angiotensin system | 1.144E-02 | 4.577E-02 | PREP |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 2.473E-02 | 7.280E-02 | ALOX5 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04520 | Adherens junction | 3.640E-02 | 7.280E-02 | PTPN1 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 3.495E-02 | 7.280E-02 | NR1H4 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04931 | Insulin resistance | 5.319E-02 | 7.663E-02 | PTPN1 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 5.462E-02 | 7.663E-02 | ALOX5 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 5.747E-02 | 7.663E-02 | ALOX5 |
09150 Organismal Systems | 09152 Endocrine system | hsa04910 | Insulin signaling pathway | 6.738E-02 | 8.086E-02 | PTPN1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | PTGES; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |